Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from EBOS Group Limited ( (AU:EBO) ) is now available.
EBOS Group Limited announced the application for quotation of 6,441 ordinary fully paid securities on the ASX, issued under an employee incentive scheme. This move reflects the company’s ongoing efforts to enhance employee engagement and align their interests with the company’s growth, potentially impacting its market positioning positively.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and pharmaceutical industry, providing a range of products and services including wholesale distribution, retailing, and logistics solutions primarily focused on the Australasian market.
Average Trading Volume: 143,821
Technical Sentiment Signal: Sell
Current Market Cap: A$5.36B
For a thorough assessment of EBO stock, go to TipRanks’ Stock Analysis page.